delpacibart etedesiran   Click here for help

GtoPdb Ligand ID: 14730

Synonyms: AOC 1001 | AOC-1001 | del-desiran
Compound class: Nucleic acid
Comment: Delpacibart etedesiran (AOC 1001) is structurally a monoclonal antibody (mAb)-oligonucleotide conjugate (AOC) in which the mAb binds the transferrin receptor (TFRC;) for targeted delivery of a duplex small interfering RNA (siRNA) payload that degrades the mRNA that encodes DM1 protein kinase (DMPK) [1].

This entry provides information on the siRNA as the component that mediates the agent's intended pharmacodynamic effect. Further details about the parental anti-TFRC mAb are provided in the delpacibart entry. To improve pharmacokinetics and RNA binding the nucleotides in etedesiran are chemically modified (2'-O-methyl/2'-MOE monomers), with a mixed phosphorothioate/phosphate backbone. The mAb is attached to the siRNAs via malemide linkers at Cys-R positions on the passenger strands.

Delpacibart etedesiran is proposed to reduce the global splicing defects that arise from toxic gain-of-function DMPK transcript accummulation in myocytes in myotonic dystrophy type 1.
Classification Click here for help
Compound class Nucleic acid
Compound subclass siRNA
Target DM1 protein kinase (DMPK) mRNA
International Nonproprietary Names Click here for help
INN number INN
12400 delpacibart etedesiran
Synonyms Click here for help
AOC 1001 | AOC-1001 | del-desiran
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1375
Other databases
CAS Registry No. 2653183-68-5 (source: WHO INN record)
Search PubMed clinical trials delpacibart etedesiran
Search PubMed titles delpacibart etedesiran
Search PubMed titles/abstracts delpacibart etedesiran